The role of extracellular vesicles in prostate cancer with clinical applications. Issue 5 (May 2020)

• Record Type: Journal Article
• Authors: Tai, Yu-Ling; Lin, Chun-Jung; Li, Tsai-Kun; Shen, Tang-Long; Hsieh, Jer-Tsong; Chen, Benjamin P C
• Is Part Of: Endocrine-related cancer. Volume 27:Issue 5(2020)
• Page Start: R133
• Page End: R144
• Publication Date: 2020-05
• Subjects: extracellular vesicles -- prostate cancer -- diagnostic biomarker -- prognostic biomarker; Endocrine glands -- Cancer -- Periodicals; Endocrinology -- Periodicals; Cancer -- Endocrine aspects -- Periodicals; 616.9944005
• DOI: 10.1530/ERC-20-0021
• Languages: English
• ISSNs: 1351-0088

Abstract

Abstract : In mammalian cells, extracellular vesicles (EVs) derived from the endosomal system carry many different kinds of bioactive molecule to deliver to recipient cells in a paracrine or endocrine manner. EVs can mediate local and systemic intercellular communications, including reeducating stromal cells, remodeling the architecture of the tumor microenvironment, modulating cancer metabolism and metastases, or even conferring drug resistance. Because the molecular and functional characteristics of prostate cancer (PCa) evolve over time, the bioactive molecule profiles/signatures of tumor-derived EVs (TDEs) reflect the real-time status of cancer cells. TDEs appear to be valuable diagnostic and prognostic biomarkers as well as potential therapeutic vehicles, suggesting their essential role in precision medicine of disease management. We summarized critical aspects of TDEs in PCa and discussed their potential clinical applications.